EpiBiologics (Series B)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 12, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$107,000,000
Company Info
Organizations Involved
GV, Johnson & Johnson, Novartis Venture Fund, Aulis Capital, Avego BioScience Capital, Samsara BioCapital, Polaris Partners, Digitalis Ventures, Taiho Ventures, Vivo Capital, Codon Capital, Mission BioCapital
Market
Healthcare
Location
San Mateo, California, USA
Coinvestors
Johnson & Johnson, Novartis Venture Fund, Aulis Capital, Avego BioScience Capital, Samsara BioCapital, Polaris Partners, Digitalis Ventures, Taiho Ventures, Vivo Capital, Codon Capital, Mission BioCapital
Company Description

EpiBiologics is a leader in tissue-selective extracellular protein degradation.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement